A report released late last week named Indiana as one of only seven states in the U.S. that covers a full range of evidence-based treatments to help Medicaid recipients stop smoking.
The Morbidity and Mortality Weekly Report, published by the Center for Disease Control and Prevention (CDC), took nine treatments into account – individual counseling, group counseling, nicotine patches, nicotine gum, nicotine lozenges, nicotine inhalers, Bupropion and Varenicline. Indiana covers all of these for Medicaid enrollees, the report said.
The report said that by adopting all nine measures, states could reduce smoking-related morbidity and health-care costs among Medicaid recipients. As smoking is more common among those covered by Medicaid, smoking-related diseases are a large contributor to the program's costs, the report said.
According to the report, 30.1 percent of the country's adult Medicaid enrollees smoke, while only 18.1 percent of U.S. adults of all ages smoke. States that provide these treatments and limit barriers to accessing them could significantly reduce Medicaid costs, the report said.
States that provide more comprehensive coverage in this arena also tend to see more Medicaid enrollees quit smoking, the report said.
In addition to Indiana, Connecticut, Massachusetts, Minnesota, Nevada, Pennsylvania and Vermont provided Medicaid enrollees with all nine evidence-based treatments taken into consideration by the CDC.
To read more about the report and its findings, visit the CDC's website.
For more information on the services Indiana provides to help people stop smoking, visit the state's tobacco prevention and cessation website.